1) plasma coagulation zymogen
血浆凝血酶原
1.
The clinical effects of the two groups and the ch anges of blood gas analysis,segment of plasma coagulation zymogen 1 plus 2 (F1+ 2) and fibrinogen (Fg) were observed.
观察治疗前后两组临床疗效和血气分析、血浆凝血酶原片段1+2(F1+2)及纤维蛋白原(Fg)的变化。
2) Protein induced by vitamin K absence Ⅱ
血浆异常凝血酶原
3) plasma prothrombin fragment
血浆凝血酶原片段
1.
The levels of plasma prothrombin fragment 1+2 in chronic urticaria patients;
慢性荨麻疹患者血浆凝血酶原片段F1+2水平的研究
4) PT
[英][,pi: 'ti:] [美]['pi 'ti]
血浆凝血酶原时间
1.
Clinical value of serum PT in patients with cirrhosis;
血浆凝血酶原时间测定对肝硬化的临床价值
5) prothrombin
[英][prəu'θrɔmbin] [美][pro'θrɑmbɪn]
凝血酶原
1.
Purification of human prothrombin by hypersaturated ammonium sulfate suspension;
过饱和硫酸铵悬浮法提纯人凝血酶原
2.
Study on the Association of Prothrombin Gene Polymorphism(G20210A) with Breast Cancer and Gastric Cancer;
凝血酶原G20210A遗传多态性与恶性肿瘤关系的研究
3.
Study on the Mutation of Prothrombin G20210A in Patients with Coronary Heart Disease;
凝血酶原G20210A突变与冠心病的相关性研究
6) Prothrombinase
[prəu'θrɔmbineis]
凝血酶原酶
1.
Objective To investigate the changes of fgl 2 prothrombinase mRNA in peripheral mononuclear cells in patients with fulminant h apatitis and its clinical significance.
目的 探讨重型肝炎患者外周血单个核细胞 (PBMNC)中fgl2凝血酶原酶mRNA的变化及其意义。
补充资料：血浆凝血酶原
血浆凝血酶原
是一种凝血因子，为单链糖蛋白(分子量6500），在活化的X因子作用下可使凝血酶原转变成凝血酶。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条